Literature DB >> 20462831

Biomarkers in colorectal cancer: the future is getting closer.

D Roda, A Cervantes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20462831     DOI： 10.1007/s12094-010-0498-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  9 in total

Review 1.  Biomarkers in colorectal cancer.

Authors:  B Markman; V Rodríguez-Freixinos; J Tabernero
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

2.  Randomized clinical trials with biomarkers: design issues.

Authors:  Boris Freidlin; Lisa M McShane; Edward L Korn
Journal:  J Natl Cancer Inst       Date:  2010-01-14       Impact factor: 13.506

Review 3.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

4.  Histological Grading of Rectal Cancer: (Section of Pathology).

Authors:  C Dukes
Journal:  Proc R Soc Med       Date:  1937-02

5.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

6.  Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

Authors:  Sumithra J Mandrekar; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

Review 7.  Genetic prognostic and predictive markers in colorectal cancer.

Authors:  Axel Walther; Elaine Johnstone; Charles Swanton; Rachel Midgley; Ian Tomlinson; David Kerr
Journal:  Nat Rev Cancer       Date:  2009-06-18       Impact factor: 60.716

Review 8.  Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.

Authors:  Alberto Bardelli; Salvatore Siena
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

Review 9.  Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

Authors:  Salvatore Siena; Andrea Sartore-Bianchi; Federica Di Nicolantonio; Julia Balfour; Alberto Bardelli
Journal:  J Natl Cancer Inst       Date:  2009-09-08       Impact factor: 13.506
  9 in total
  1 in total

1.  High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.

Authors:  S S Kumar; Y Tomita; J Wrin; M Bruhn; A Swalling; M Mohammed; T J Price; J E Hardingham
Journal:  Clin Transl Oncol       Date:  2016-12-22       Impact factor: 3.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.